EUVIMEDSkopri EUVIMED
ÜbersichtsarbeitOpen access

Toward Personalized Medicine Approaches for Parkinson Disease Using Digital Technologies

Amit Khanna iD, Graham Jones iD

JMIR Formative Research · 2023-09-27 · 7 · e47486

DOI: 10.2196/47486 ↗

At a glance

Übersichtsarbeit in JMIR Formative Research, published online on 2023-09-27. Written by Amit Khanna and 1 co-authors. Institution: Neuroscience Global Drug Development, Novartis Pharma AG, Basel, Switzerland. Major MEDLINE topics: Parkinson Disease, Precision Medicine, Digital Technology. Cited 15 times so far (Crossref); 80 references. The full text is freely available in PubMed Central.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Parkinson disease (PD) is a complex neurodegenerative disorder that afflicts over 10 million people worldwide, resulting in debilitating motor and cognitive impairment. In the United States alone (with approximately 1 million cases), the economic burden for treating and caring for persons with PD exceeds US $50 billion and myriad therapeutic approaches are under development, including both symptomatic- and disease-modifying agents. The challenges presented in addressing PD are compounded by observations that numerous, statistically distinct patient phenotypes present with a wide variety of motor and nonmotor symptomatic profiles, varying responses to current standard-of-care symptom-alleviating medications (L-DOPA and dopaminergic agonists), and different disease trajectories. The existence of these differing phenotypes highlights the opportunities in personalized approaches to symptom management and disease control. The prodromal period of PD can span across several decades, allowing the potential to leverage the unique array of composite symptoms presented to trigger early interventions. This may be especially beneficial as disease progression in PD (alongside Alzheimer disease and Huntington disease) may be influenced by biological processes such as oxidative stress, offering the potential for individual lifestyle factors to be tailored to delay disease onset. In this viewpoint, we offer potential scenarios where emerging diagnostic and monitoring strategies might be tailored to the individual patient under the tenets of P4 medicine (predict, prevent, personalize, and participate). These approaches may be especially relevant as the causative factors and biochemical pathways responsible for the observed neurodegeneration in patients with PD remain areas of fluid debate. The numerous observational patient cohorts established globally offer an excellent opportunity to test and refine approaches to detect, characterize, control, modify the course, and ultimately stop progression of this debilitating disease. Such approaches may also help development of parallel interventive strategies in other diseases such as Alzheimer disease and Huntington disease, which share common traits and etiologies with PD. In this overview, we highlight near-term opportunities to apply P4 medicine principles for patients with PD and introduce the concept of composite orthogonal patient monitoring.

Subjects

MeSH terms (MEDLINE)

Parkinson DiseasePrecision MedicineDigital TechnologyHumansDisease Progression

Author keywords

Parkinson diseasecognitive impairmentdebilitating diseasedigital healthdigital technologydisease controleconomic burdeninterventionmonitoringneurodegenerative disorderpersonalized medicinesymptom managementwearables

Authors and institutions

  • Neuroscience Global Drug Development, Novartis Pharma AG, Basel, Switzerland.
  • GDD Connected Health and Innovation Group, Novartis Pharmaceuticals, East Hanover, NJ, United States.
  • Clinical and Translational Science Institute, Tufts University Medical Center, Boston, MA, United States.

ORCID profiles: Amit Khanna, Graham Jones

Cite

APA

Khanna, A., & Jones, G. (2023). Toward Personalized Medicine Approaches for Parkinson Disease Using Digital Technologies. JMIR Formative Research, 7, e47486. https://doi.org/10.2196/47486

Vancouver

Khanna A, Jones G. Toward Personalized Medicine Approaches for Parkinson Disease Using Digital Technologies. JMIR Formative Research. 2023;7:e47486. doi:10.2196/47486

BibTeX
@article{Khanna2023,
  author = {Khanna, Amit and Jones, Graham},
  title = {Toward Personalized Medicine Approaches for Parkinson Disease Using Digital Technologies},
  journal = {JMIR Formative Research},
  year = {2023},
  volume = {7},
  pages = {e47486},
  doi = {10.2196/47486}
}
Start for free →